[1] Bogdanos D,Gao B,Eric GM. Liver Immunology. Compr Physiol,2013,3(2):567-598.
[2] Gao B.Basic liver immunology. Cell Mol Immunol,2016,13:265-266.
[3] Knolle P,Wohlleber D.Immunological functions of liver sinusoidal endothelial cells. Cell Mol Immunol,2016,13:347-353.
[3] Tsutsui H,Nishiguchi S.Importance of Kupffer cells in the development of acute liver injuries in mice. Int J Mol Sci,2014,15:7711-7730.
[4] Horst A,Neumann K,Diehland L,et al.Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol,2016,13(3):277-292.
[5] Mikulak J,Bruni E,Oriolo F,et al.Hepatic natural killer cells:Organ-specific sentinels of liver immune homeostasis and physiopathology. Front Immunol,2019,10:946-949.
[6] Peng H,Wisse E,Tian Z.Liver natural killer cells:subsets and roles in liver immunity. Cell Mol Immunol,2016,13:328-336.
[7] Jiang X,Chen Y,Peng H,et al. Memory NK cells:why do they reside in the liver Cell Mol Immunol,2013,10:196-201.
[8] Bandyopadhyay K,Marrero I,Kumar V.NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol,2016,13:337-346.
[9] Oche A,Tiegs G,Neumann K.Type 2 innate lymphoid cells in liver and gut:From current knowledge to future perspectives. Int J Mol Sci,2019,20:1896-1899.
[10] Bolte F,Rehermann B.Mucosal-associated invariant T cells in chronic inflammatory liver disease. Semin Liver Dis,2018,38(1):60-65.
[11] Liang Y,Kwota Z, Sun J.Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection. Int Immunopharmacol,2016,39:106-112.
[12] Yang S,Wang L,Pan W,et al.MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. J Hepatol,2019,8278(19):30299-30305.
[13] Xia Y,Pan W,Ke X,et al.Differential escape of HCV from CD8+T cell selection pressure between China and Germany depends on the presenting HLA class I molecule. J Viral Hepat,2019,26(1):73-82.
[14] Patra T,Ray R,Ray R.Strategies to circumvent host innate immune response by hepatitis C virus. Cells,2019,8:274-278.
[15] Than N,Jeffery H,Oo Y.Autoimmune hepatitis:Progress from global immunosuppression to personalised regulatory T cell therapy. Can J Gastroenterol Hepatol,2016,7181685:1-12.
[16] Sebode M,Schulz L,Lohse A.“Autoimmune(-like)” Drug and herb induced liver injury:New insights into molecular pathogenesis. Int J Mol Sci,2017,18:1954-1959.
[17] Byun J,Yi H.Hepatic immune microenvironment in alcoholic and nonalcoholic liver disease. Bio Med Res Int,2017,6862439:1-12.
[18] Vonghia L,Van Herck MA,Weyler J,et al.Targeting myeloid-derived cells:New frontiers in the treatment of non-alcoholic and alcoholic liver disease. Front Immunol,2019,10:563-567.
[19] Seo W,Jeong W.Hepatic non-parenchymal cells:Master regulators of alcoholic liver disease World [J] Gastroenterol,2016,22(4):1348-1356.
[20] Nagy LE.The role of innate immunity in alcoholic liver disease. Alcohol Res,2017,37(2):238-245.
[21] Ringelhan M,Pfister D,O’Connor T,et al.The immunology of hepatocellular carcinoma. Nat Immunol,2018,23:256-263. |
